Aier Eye Hospital Group Co., Ltd. operates as an ophthalmic medical company in China, Hong Kong, Europe, the United States, and Southeast Asia. It offers diagnosis and treatment services for various ophthalmic diseases, and surgical and medical optometry services, as well as lens fitting services for fundus diseases, glaucoma, and cataract. The company also provides training courses for cataract cases, ICL surgery, and presbyopia surgery. Aier Eye Hospital Group Co., Ltd. was founded in 2002 and is headquartered in Changsha, China.
Research context
Aier Eye Hospital Group Co., Ltd appears in PyInvesting’s Shenzhen Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Medical Care Facilities
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Aier Eye Hospital Group Co., Ltd is currently in a long term uptrend where the price is trading 18.2% above its 200 day moving average.
From a valuation standpoint, the stock is 151.3% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 24.2.
Aier Eye Hospital Group Co., Ltd's total revenue rose by 47.6% to $4B since the same quarter in the previous year.
Its net income has increased by 62.3% to $870M since the same quarter in the previous year.
Finally, its free cash flow grew by 157.0% to $2B since the same quarter in the previous year.
Based on the above factors, Aier Eye Hospital Group Co., Ltd gets an overall score of 4/5.